Oryzon Genomics S.A Stock (BME:ORY)

SPAIN |MC |EUR

Price
3.07
Change
1.82%
Today's Range
€3.00 - €3.11
52-Week Range
€2.61 - €4.39
Market Cap
€161.98M
Volume
116.22K

About Oryzon Genomics S.A (BME:ORY)

(BME:ORY) Oryzon Genomics S.A., a clinical phase biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for the treatment of oncological and CNS disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, a LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases, as well as other programs at various stages of development. The company was founded in 2000 and is based in Cornellà de Llobregat, Spain.
Show more

ORY Stock Price

Statistics Highlights (BME:ORY)

Shares Outstanding 52.76M Beta 1.04
Public Float 42.60M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 19.15% Ex-Dividend Date
Held by Institutions 0.90% IPO Date -

ORY Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue €0.00 €10.28M €0.00
EBITDA €-4.16M €-3.65M €-2.76M
Net Income €-3.40M €-3.68M €-1.18M
Total Assets €94.11M €80.09M €67.45M
Total Cash €39.60M €35.11M €34.32M
Total Debt
Jun 21 Mar 21 Dec 20
Revenue €0.00 €0.00 €0.00
EBITDA €-1.53M €-1.69M €-982.25K
Net Income €800.92K €-1.82M €-1.13M
Total Assets €95.28M €95.41M €94.11M
Total Cash €33.73M €38.51M €39.60M
Total Debt

ORY Stock Price History

Oryzon Genomics S.A Annual Stock Price History

Year Open Close Change
2022 €2.65 €3.07 15.85%
2021 €3.62 €2.65 -26.80%
2020 €2.86 €3.62 26.80%

Oryzon Genomics S.A Daily Stock Price History

Date Open High Low Close Change Volume
Jan 21, 2022 €3.10 €3.25 €3.05 €3.12 -2.50% 312.99K

(BME:ORY) Stock Price FAQs

What is today's stock price of Oryzon Genomics S.A (BME:ORY)?

  • The current stock price of Oryzon Genomics S.A (BME:ORY) is €3.07.
  • Today ORY stock price opened at €3.02 after previous close of €3.02.
  • During the day, Oryzon Genomics S.A stock quote has varied from a low of €3.00 to a high of €3.11.

What is Oryzon Genomics S.A's 52-week change?

  • ORY 52-week high stock quote is €4.40, which is 43.20% above the current share price.
  • The Oryzon Genomics S.A (BME:ORY) 52-week low stock price is €2.61, which is 15.00% below the current share price.
  • Oryzon Genomics S.A share price volatility (52-week beta) is 1.04.

Oryzon Genomics S.A (BME:ORY) FAQ

How Much is Oryzon genomics s.a Worth?

Oryzon genomics s.a's worth today based on market capitalisation is €161.98M

How much dividend does Oryzon genomics s.a Pay?

The current annualized dividend payout for ORY stock is €0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Oryzon genomics s.a's "Dividend" Section

When is the next earnings date for Oryzon genomics s.a (BME:ORY)?

Oryzon genomics s.a is expected to report earnings on May 05 ,2022.
View More Details on Oryzon genomics s.a's 'Earnings' Section

What is Oryzon genomics s.a’s Price to Earning (PE) ratio?

ORY stock also has a Price to Sales (P/S) ratio of 18.62.

What is the Oryzon genomics s.a's ticker?

Oryzon genomics s.a trades on the Madrid stock market in Spain under the ticker symbol "ORY". Oryzon genomics s.a’s stock symbol can also be displayed as "BME:ORY".

Who are the owners of Oryzon genomics s.a?

Oryzon genomics s.a (BME:ORY) is owned by 0.90% institutional shareholders and by 19.15% insiders. The rest is owned by the public.
Explore More Details on Oryzon genomics s.a's “Ownership” Section

Who are the key executives of Oryzon genomics s.a (ORY)?

Oryzon genomics s.a's key executive team includes the following managers:

  • Dr. Carlos Manuel Buesa Arjol, Co-Founder, Chairman, CEO & Pres (NA)
  • Mr. Enric Rello Condomines, Director of Operations, COO & CFO (NA)
  • Mr. Jordi Xaus Pey, Chief Scientific Officer (NA)
  • Dr. Michael Thomas Ropacki Ph.D., Chief Medical Officer of CNS (NA)
  • Mr. Augusto Pinel Rubio, Sec. (NA)

What is Oryzon genomics s.a’s Sector & Industry Classification?

Oryzon genomics s.a (BME:ORY) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Oryzon genomics s.a?

Currently the number of employees working for Oryzon genomics s.a is 44.

Where are Oryzon genomics s.a's Headquarters?

Oryzon genomics s.a (BME:ORY) is headquartered in Spain.

What are Oryzon genomics s.a's Address and Phone Number?

Oryzon genomics s.a’s mailing address is Sant Ferran 74, Cornellà de Llobregat, Spain, 08940.
The company’s phone number is 34 93 515 13 13.

What is the official website for Oryzon genomics s.a?

Oryzon genomics s.a’s official website is http://www.oryzon.com